Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - gastroenterology & urology - fresenius multifiltrate kit is for continuous renal replacement therapy. ultraflux av 600s and av1000s are designed for single use in acute dialysis with machine assisted continuous veno-venous haemofiltration, haemodialysis and haemodiafiltration (cvvh, cvvhd, cvvhdf). av600s is also suitable for a non-machine assisted continuous arterio-venous haemofiltration or haemodialysis (cavh, cavhd). av1000s is specifically recommended for high volume cvvh/cvvhdf. ultraflux emic2 are designed for single use in acute dialysis with machine assisted continuous veno-venous haemodialysis (cvvhd) as well as for the sledd- therapy (slow extended daily dialysis). blood line/ tubing systems (cassette multifiltrate, cassette cica multifiltrate, dialysate system multifiltrate) are intended for single use only for extracorporeal blood purification.

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - gastroenterology & urology - fresenius multifiltrate kit 5 pre post cvvh 600 is for continuous renal replacement therapy . ultraflux av 600s are designed for single use in acute dialysis with machine assisted continuous veno-venous haemofiltration, haemodialysis and haemodiafiltration (cvvh, cvvhd, cvvhdf). it is also suitable for a non-machine assisted conditions arterio-venous haemofiltration or haemodialysis (cavh, cavhd). multifiltrate cassette and dialysate hv-cvvh substituate set are intended for single use only for extracorporeal blood purification. for use with multifiltrate acute dialysis machines.

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - fresenius blood lines, tubing systems, and accessories are intended for use in the extracorporeal purification of blood in the framework of renal replacement therapy.

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - fresenius blood lines, tubing systems, and accessories are intended for use in the extracorporeal purification of blood in the framework of renal replacement therapy.

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - fresenius extension asv y bcv syringe pump infusion line is single use connecting lines for extension of infusion and transfusion sets, for use with pressure infusion equipment.

Singapore - English - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - fresenius blood lines, tubing systems, and accessories are intended for use in the extracorporeal purification of blood in the framework of renal replacement therapy.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) to permit the emergency use of the unapproved product, fresenius propoven 2% (propofol 20 mg/ml) emulsion 100 ml, to maintain sedation via continuous infusion in patients greater than 16 years old who require mechanical ventilation in an intensive care unit (icu) setting. caution: there is a risk of unintentional overdose with this unapproved product. fresenius propoven 2% emulsion contains the same active ingredient, propofol, as fda-approved diprivan injectable emulsion usp 10 mg/ml, but contains double the concentration. because of this difference in concentration between this unapproved product and the fda-approved product, there is a risk of unintentional overdose. fresenius propoven 2% emulsion 100ml is not an fda-approved drug in the united states. however, fda has issued an eua permitting the emergency use of fresenius propoven 2% emulsion during the covid-19 pandemic. the scope of the eua is limited as follows

United States - English - NLM (National Library of Medicine)

fresenius kabi austria gmbh - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) to permit the emergency use of the unapproved product, fresenius propoven 2% (propofol 20 mg/ml) emulsion 100 ml, to maintain sedation via continuous infusion in patients greater than 16 years old who require mechanical ventilation in an intensive care unit (icu) setting. caution: there is a risk of unintentional overdose with this unapproved product. fresenius propoven 2% emulsion contains the same active ingredient, propofol, as fda-approved diprivan injectable emulsion usp 10 mg/ml, but contains double the concentration. because of this difference in concentration between this unapproved product and the fda-approved product, there is a risk of unintentional overdose. fresenius propoven 2% emulsion 100ml is not an fda-approved drug in the united states. however, fda has issued an eua permitting the emergency use of fresenius propoven 2% emulsion during the covid-19 pandemic. the scope of the eua is limited as follows

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - 11226 - dialyser, peritoneal unit - to treat renal failure by removing fluid and metabolic wastes from the blood by peritoneal dialysis.

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - busulfan - hematopoietic stem cell transplantation - alkyl sulfonates - busulfan fresenius kabi followed by cyclophosphamide (bucy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (hpct) in adult patients when the combination is considered the best available option.busulfan fresenius kabi followed by cyclophosphamide (bucy4) or melphalan (bumel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.